尿道感染檢測市場規模、佔有率和成長分析（檢測套組、感染類型、檢測類型、最終用戶和地區）- 產業預測 2025-2032

2023 年全球尿道感染檢測市場規模為 6.102 億美元，預計將從 2024 年的 6.3827 億美元成長到 2032 年的 9.1466 億美元，預測期內（2025-2032 年）的複合年成長率為 4.6%。

受診斷技術的進步以及人們對主要影響女性的泌尿道感染 ( 尿道感染)的認知不斷提高的推動，全球尿道感染(UTI) 檢測市場有望成長。主要促進因素包括尿道結石盛行率上升、醫療支出增加以及人口老化使人們更容易受到這些感染疾病。診斷工具的創新，包括即時診斷和無創技術，正在改善早期檢測和管理。個人化和預防醫療的轉變進一步推動了先進診斷解決方案的採用。然而，某些測試方法的準確性和替代療法的競爭等挑戰可能會抑製成長。總體而言，由於感染疾病控制仍然是醫療保健的首要任務，預計未來幾年尿道結石檢測市場將穩定擴大。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究
• 技術進步

尿道感染檢測市場規模（檢測套組及複合年成長率分類）（2025-2032）

• 市場概況
• 家庭檢測套組
• 臨床檢測套組

尿道感染檢測市場規模（依感染類型及複合年成長率）（2025-2032）

• 市場概況
• 尿道炎
• 膀胱炎
• 腎盂腎炎

尿道感染檢測市場規模（按檢測類型和複合年成長率） (2025-2032)

• 市場概況
• 尿液檢查
• 尿液培養
• 藥敏試驗

尿道感染檢測市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 全科醫生（GP）
• 泌尿系統
• 泌尿系統- 婦科醫生
• 醫院檢查室
• 參考實驗室
• 醫院急診部
• 緊急護理
• 其他

尿道感染檢測市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Abbott Laboratories（USA）
• Becton, Dickinson and Company（BD）（USA）
• bioMerieux SA（France）
• Thermo Fisher Scientific Inc.（USA）
• Siemens Healthineers AG（Germany）
• F. Hoffmann-La Roche Ltd（Switzerland）
• Bio-Rad Laboratories, Inc.（USA）
• Cepheid（USA）（Parent Company：Danaher Corporation）
• Hologic, Inc.（USA）
• Quidel Corporation（USA）
• Meridian Bioscience, Inc.（USA）
• Luminex Corporation（USA）
• QIAGEN NV（Netherlands）
• Beckman Coulter, Inc.（USA）（Parent Company：Danaher Corporation）
• Sysmex Corporation（Japan）
• OraSure Technologies, Inc.（USA）
• GenMark Diagnostics, Inc.（USA）
• Mesa Biotech, Inc.（USA）
• Alere Inc.（USA）（Parent Company：Abbott Laboratories）
• T2 Biosystems, Inc.（USA）

結論和建議

Global Urinary Tract Infection Testing Market size was valued at USD 610.2 million in 2023 and is poised to grow from USD 638.27 million in 2024 to USD 914.66 million by 2032, growing at a CAGR of 4.6% during the forecast period (2025-2032).

The global urinary tract infection (UTI) testing market is poised for growth, fueled by advancements in diagnostic technology and increasing awareness of UTIs, which predominantly affect women. Key drivers include a rising incidence of UTIs, elevated healthcare spending, and an aging population more vulnerable to these infections. Innovations in diagnostic tools, such as point-of-care tests and non-invasive methodologies, are improving early detection and management. The shift towards personalized and preventive healthcare further propels the adoption of sophisticated diagnostic solutions. However, challenges like the accuracy of certain testing methods and competition from alternative treatments may temper growth. Overall, as infection management remains a priority in healthcare, the UTI testing market is expected to experience steady expansion in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Urinary Tract Infection Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Urinary Tract Infection Testing Market Segments Analysis

Global Urinary Tract Infection Testing Market is segmented by Test Kit, Infection Type, Test Type, End User and region. Based on Test Kit, the market is segmented into Home Test Kits and Laboratory Test Kits. Based on Infection Type, the market is segmented into Urethritis, Cystitis and Pyelonephritis. Based on Test Type, the market is segmented into Urinalysis, Urine Cultures and Susceptibility Testing. Based on End User, the market is segmented into General Practitioners (GPs), Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories, Hospital Emergency Departments, Urgent Care and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Urinary Tract Infection Testing Market

The global urinary tract infection (UTI) testing market is profoundly impacted by the rising incidence of antibiotic-resistant UTIs. The improper utilization and overprescription of antibiotics have resulted in the development of resistant bacterial strains, complicating UTI treatment strategies. This critical issue has heightened the demand for precise diagnostic methods, including urine cultures and susceptibility tests, which aid healthcare professionals in identifying effective treatments based on specific bacteria. Furthermore, the pressing need to address antibiotic resistance has led to increased investment in research for innovative therapies. This ongoing development is driving the market towards advanced solutions aimed at managing resistant UTIs while encouraging responsible antibiotic usage.

Restraints in the Global Urinary Tract Infection Testing Market

Antibiotic resistance is a major challenge impacting the global urinary tract infection (UTI) testing market. The excessive and improper use of antibiotics has resulted in the rise of drug-resistant bacteria, diminishing the effectiveness of standard treatments for UTIs. This issue complicates the management of these infections, leading to longer recovery times, escalating healthcare expenses, and a risk of severe complications for patients. Healthcare professionals must carefully balance the necessity for effective treatment against the prudent use of antibiotics to address this pressing issue. As a result, there is an increasing demand for innovative diagnostic methods and alternative treatment strategies within the UTI market.

Market Trends of the Global Urinary Tract Infection Testing Market

The global urinary tract infection (UTI) testing market is experiencing a significant shift towards Point-of-Care (POC) testing methods, driven by the need for prompt and precise diagnostics. POC tests are increasingly favored due to their ability to deliver rapid results and allow for on-site testing, thus minimizing reliance on centralized laboratories and decreasing turnaround times. This trend caters to rising consumer demands for efficient UTI diagnosis, particularly in primary healthcare environments. As innovations in technology further enhance the accuracy and efficiency of these tests, their integration into routine clinical practice is transforming UTI diagnostics and ultimately improving patient care outcomes worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Urinary Tract Infection Testing Market Size by Test Kit & CAGR (2025-2032)

• Market Overview
• Home Test Kits
• Laboratory Test Kits

Global Urinary Tract Infection Testing Market Size by Infection Type & CAGR (2025-2032)

• Market Overview
• Urethritis
• Cystitis
• Pyelonephritis

Global Urinary Tract Infection Testing Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Urinalysis
• Urine Cultures
• Susceptibility Testing

Global Urinary Tract Infection Testing Market Size by End User & CAGR (2025-2032)

• Market Overview
• General Practitioners (GPs)
• Urologists
• Urogynecologists
• Hospital Laboratories
• Reference Laboratories
• Hospital Emergency Departments
• Urgent Care
• Others

Global Urinary Tract Infection Testing Market Size & CAGR (2025-2032)

• North America (Test Kit, Infection Type, Test Type, End User)
  • US
  • Canada
• Europe (Test Kit, Infection Type, Test Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Kit, Infection Type, Test Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Kit, Infection Type, Test Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Kit, Infection Type, Test Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid (USA) (Parent Company: Danaher Corporation)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quidel Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meridian Bioscience, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (USA) (Parent Company: Danaher Corporation)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OraSure Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenMark Diagnostics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mesa Biotech, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alere Inc. (USA) (Parent Company: Abbott Laboratories)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• T2 Biosystems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations